Author

Jin Xu

Monash UniversityORCID 0000-0002-9997-8150Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jin Xu2 papers · Baylor College of Medicine

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

César de la Fuente‐NúñeziD· 1 shared Chen LiiD· 1 shared Fuyi LiiD· 1 shared Jian LiiD· 1 shared Jiangning SongiD· 1 shared Marcelo D. T. TorresiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

César de la Fuente‐NúñezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintApr 10, 2026

Modification-aware AI enables terminal chemical modifications for peptide design and discovers potent antimicrobials

Jin Xu, Marcelo D. T. Torres, Chen Li…·César de la Fuente‐Núñez

This study introduces Termini, an AI framework for designing antimicrobial peptides with terminal modifications, achieving high hit rates and therapeutic potential in vitro and in vivo.

DOI 10.64898/2026.04.09.717597

bacteria (other)proteomics

𝕏 PostBluesky